Trending...
- Timbrana Helps General Contractors Improve Jobsite Visibility and Subcontractor Accountability
- Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources
- Roots for Boots to Participate in 2026 Adams County Community Foundation Giving Spree
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Marathon Digital Holdings, Inc. ("Marathon" or the "Company") (NASDAQ: MARA) investors concerning the Company's possible violations of federal securities laws.
On February 28, 2023, Marathon announced that it was unable to timely file its fourth quarter and full year 2022 financial results and would reissue financial statements dating back to 2021 after an inquiry conducted by the SEC flagged several accounting errors.
On this news, Marathon's stock price fell $0.59, or 8.3%, to close at $6.51 per share on March 1, 2023, thereby injuring investors.
Then, on March 16, 2023, after market hours, Marathon released its fourth quarter and fiscal year 2022 financial results, reporting a net loss of $686.7 million for 2022.
More on The PennZone
On this news, Marathon's stock price fell during after-hours trading on March 16, 2023, thereby injuring investors further.
If you purchased Marathon securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
On February 28, 2023, Marathon announced that it was unable to timely file its fourth quarter and full year 2022 financial results and would reissue financial statements dating back to 2021 after an inquiry conducted by the SEC flagged several accounting errors.
On this news, Marathon's stock price fell $0.59, or 8.3%, to close at $6.51 per share on March 1, 2023, thereby injuring investors.
Then, on March 16, 2023, after market hours, Marathon released its fourth quarter and fiscal year 2022 financial results, reporting a net loss of $686.7 million for 2022.
More on The PennZone
- York County Is an EPA Radon Zone 1. Here Is What Homeowners Should Know Before Testing
- What Mold Remediation Costs in Gettysburg, PA: 2026 Price Ranges by Job Type
- Roots, Rhythm & Joy Invites Neighbors to Find Community Through Music
- New Children's Picture Book "Adam's Apple" Celebrates Childhood Curiosity and the Funny Misundersta
- Stand Strong Fencing of Hatfield Turns Every October Project Into a Cancer Donation
On this news, Marathon's stock price fell during after-hours trading on March 16, 2023, thereby injuring investors further.
If you purchased Marathon securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
0 Comments
Latest on The PennZone
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
- Electives Launches "Electives for Everyone," Making Live Expert-Led Learning Available to Every Employee
- Tax Tops the List as Wealthy Brits Plan Their Exit, La Vida Survey Finds
- "The Tree of Cinema" Installation Brought Film History and Its Audiences Together at TIFF 2026
- Detroit Lawyer Steals $600,000 Settlement Meant to Protect Child
- The Great Junk Hunt Makes Its Highly Anticipated Stop in Philadelphia (Oaks)!
- Heritage at South Brunswick Announces Special Townhome Mortgage Rate Buydown
- Heritage at Hopewell Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Townhomes
- Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton
- Ashley Russo Receives Linny Lifetime Achievement Award
- How to Choose a Heating Repair Company in Philadelphia
- Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
- Lehigh County Drug and Alcohol Celebrates Grand Opening of Journeys
- Timbrana Addresses the Missing Follow-Through in Commercial Construction Projects
- AI Agents Are Getting Their Own Computers. HRTech Leading in Vertical Harness Development
- UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
- JKS Financial Gives Back Through Light of Life Rescue Mission Food Pantry
- Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Corner Property Management AAMC Expands Presence with Clover Mill Management Agreement
- Michael Fischer Launches 'Legacy League' Podcast